Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized,...

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Sudden cardiac death (SCD) is a significant cause of mortality in individuals with cardiovascular disease.
• Identifying individuals at increased risk for SCD is crucial for timely intervention.

Purpose of the Study:

• To evaluate the effectiveness of implantable cardioverter defibrillators (ICDs) in preventing sudden cardiac death (SCD).
• To assess the impact of ICDs on all-cause mortality in at-risk populations.

Main Methods:

• Systematic review and meta-analysis of randomized controlled trials (RCTs) comparing ICDs with usual care.
• Inclusion of eight trials with 4909 patients and 1154 deaths.
• Data extraction and analysis performed by two independent reviewers.

Main Results:

• ICDs significantly reduced sudden cardiac death (RR, 0.43) and all-cause mortality (RR, 0.74) compared to usual care.
• ICD efficacy in preventing sudden cardiac death was consistent in both secondary prevention (RR, 0.50) and primary prevention (RR, 0.37) groups.
• The benefit of ICDs on total mortality varied within primary prevention trials based on baseline risk.

Conclusions:

• Implantable cardioverter defibrillators are effective in preventing sudden cardiac death irrespective of a patient's baseline risk.
• The impact of ICDs on overall mortality is influenced by the patient's risk for arrhythmic death.
• Accurate patient risk stratification is essential for optimizing resource allocation for ICD implantation.